These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 17294161

  • 1. Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children.
    Schaaf HS, Victor TC, Engelke E, Brittle W, Marais BJ, Hesseling AC, van Helden PD, Donald PR.
    Eur J Clin Microbiol Infect Dis; 2007 Mar; 26(3):203-5. PubMed ID: 17294161
    [Abstract] [Full Text] [Related]

  • 2. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY, Bilgin K, Uzun M, Durupinar B.
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [Abstract] [Full Text] [Related]

  • 3. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U, Akhmetova A, Rakhimova S, Belova E, Alenova A, Bismilda V, Chingissova L, Ismailov S, Ramanculov E, Momynaliev K.
    Jpn J Infect Dis; 2011 Apr; 64(3):253-5. PubMed ID: 21617314
    [Abstract] [Full Text] [Related]

  • 4. Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Valvatne H, Syre H, Kross M, Stavrum R, Ti T, Phyu S, Grewal HM.
    J Antimicrob Chemother; 2009 Oct; 64(4):694-701. PubMed ID: 19710078
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
    Imperiale BR, Di Giulio ÁB, Adrián Cataldi A, Morcillo NS.
    J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
    [Abstract] [Full Text] [Related]

  • 6. [Surveillance of antituberculosis-drug resistance in Cuba, 2010-2011].
    Lemus D, Echemendía M, Díaz R, Llop A, Llanes MJ.
    Biomedica; 2014 Apr; 34 Suppl 1():108-13. PubMed ID: 24968042
    [Abstract] [Full Text] [Related]

  • 7. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P, Jadaun GP, Das R, Gupta UD, Srivastava K, Chauhan A, Sharma VD, Chauhan DS, Katoch VM.
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [Abstract] [Full Text] [Related]

  • 8. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z, Zhang J, Song H, Zhang X, Li Y, Tian M, Liu Y, Zhao Y, Li C.
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1436-41, i. PubMed ID: 20937184
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
    Gui XH, Xu P, Zhao M, Wang LL, Wu J, Li J, Gao Q, Mei J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
    AlMatar M, Var I, Kayar B, Eker E, Kafkas E, Zarifikhosroshahi M, Köksal F.
    Curr Pharm Biotechnol; 2019 Jan; 20(4):317-326. PubMed ID: 30854955
    [Abstract] [Full Text] [Related]

  • 11. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
    Imperiale BR, Zumárraga MJ, Di Giulio AB, Cataldi AA, Morcillo NS.
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
    [Abstract] [Full Text] [Related]

  • 12. Antituberculosis drug resistance in isolates of Mycobacterium tuberculosis complex in southeast Spain.
    Montiel Quezel-Guerraz N, Sánchez-Porto A, Ortega Torres M, Pérez Santos MJ, Acosta F, Guzman A, Correa Ruiz A, Bérmudez Ruiz P.
    J Glob Antimicrob Resist; 2020 Mar; 20():183-186. PubMed ID: 31421285
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the GenoType MTBDR assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
    Saglik I, Oz Y, Kiraz N.
    Indian J Med Microbiol; 2014 Mar; 32(3):318-22. PubMed ID: 25008829
    [Abstract] [Full Text] [Related]

  • 14. Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Köser CU, Summers DK, Archer JA.
    J Antimicrob Chemother; 2011 Mar; 66(3):686-7; author reply 687. PubMed ID: 21177677
    [No Abstract] [Full Text] [Related]

  • 15. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
    Aydın F, Kaklıkkaya N, Bayramoğlu G, Ozkul G, Buruk K, Dinç U, Köse T, Dede R.
    Mikrobiyol Bul; 2011 Jan; 45(1):36-42. PubMed ID: 21341157
    [Abstract] [Full Text] [Related]

  • 16. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Bergmann JS, Woods GL.
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):153-6. PubMed ID: 9294706
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of the microplate nitrate reductase assay and the rezasurin microtitre assay for the rapid detection of multidrug resistant Mycobacterium tuberculosis clinical isolates.
    Coban AY, Uzun M, Akgunes A, Durupinar B.
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):578-81. PubMed ID: 22850946
    [Abstract] [Full Text] [Related]

  • 18. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
    Schaaf HS, Victor TC, Venter A, Brittle W, Jordaan AM, Hesseling AC, Marais BJ, van Helden PD, Donald PR.
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.
    Parsons LM, Salfinger M, Clobridge A, Dormandy J, Mirabello L, Polletta VL, Sanic A, Sinyavskiy O, Larsen SC, Driscoll J, Zickas G, Taber HW.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2218-25. PubMed ID: 15917515
    [Abstract] [Full Text] [Related]

  • 20. Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.
    Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B, Van Deun A, Barrera L, Boulahbal F, Richter E, Martín-Casabona N, Arias F, Zemanova I, Drobniewski F, Santos Silva A, Coulter C, Lumb R, Cegielski JP.
    Int J Tuberc Lung Dis; 2012 Jun; 16(3):355-7. PubMed ID: 22640449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.